Research

Topics Publications In progress publications Communications

Packages

AnaQol Project PRO-online R Packages Online R-package

Life of the unit

Projects Collaborations PhD thesis Traineeships Traineeships propositions Seminars

Next seminars

Last publications

28 juin 2019 Gérardin M, Rousselet M, Caillet P, Grall-Bronnec M, Loué P, Jolliet P, Victorri-Vigneau C (2019) French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol . BMJ open, 9: e027443.

01 juin 2019 Caillon J, Grall-Bronnec M, Perrot B, Leboucher J, Donnio Y, Romo L, Challet G (2019) Effectiveness of At-Risk Gamblers' Temporary Self-Exclusion from Internet Gambling Sites. J Gambl Stud, 35(2): 601-615.

01 mai 2019 Karsenti D, Tharsis G, Zeitoun J, Denis P, Perrot B, Coelho J, Bellaiche G, Charbit L, Hakoune J, Doumet S, Sion-Rohart E, Cavicchi M, Zago J (2019) Comparison of 20-gauge Procore® and 22-gauge Acquire® needles for EUS-FNB of solid pancreatic masses: an observational study. Scandinavian Journal of Gastroenterology, 8: 1-7.

11 avril 2019 Montassier E, Javaudin F, Moustafa F, Nandjou D, Maignan M, Hardouin JB, Annoot C, Ogielska M, Orer PL, Schotté T, Bouget J, Agha Babaei S, Raynal PA, Eche A, Duc AT, Cojocaru RA, Benaouicha N, Potel G, Batard E, Talan DA. (2019) Guideline-Based Clinical Assessment Versus Procalcitonin-Guided Antibiotic Use in Pneumonia: A Pragmatic Randomized Trial. Ann Emerg Med(19): 30147-7.

09 avril 2019 Rouquette A, Hardouin JB, Vanhaesebrouck A, Sébille V, Coste J (2019) Differential Item Functioning (DIF) in composite health measurement scale: recommendations for characterizing DIF with meaningful consequences within the Rasch model framework.. PLOS One, 14(4): e0215073.

Updated

17 juillet 2019

Eric Dailly

Situation

Poste : Praticien Hospitalier Universitaire - HDR
Institution : CHU Nantes - Université de Nantes

Publications scientifiques

Articles dans une revue internationale

1. Le Turnier P, Navas D, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme Y, Hoff J, Chiffoleau A, Dary M, Leclair-Visonneau L, Gregoire M, Pere M, Boutoille D, Sébille V, Dailly E, Asseray N, High-Dose Ceftriaxone CNS Infections Study Group (2019) Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort study. J Antimicrob Chemother: doi: 10.1093/jac/dky553. [Epub ahead of print].
2. Bouquié R, Hernando H, Deslandes G, Ben Mostefa Daho A, Renaud C, Grall-Bronnec M, Dailly E, Jolliet P (2015) Chiral on-line solid phase extraction coupled to liquid chromatography-tandem mass spectrometry assay for quantification of (R) and (S) enantiomers of methadone and its main metabolite in plasma. Talanta, 134: 373-378.
3. Bouquié R, Deslandes G, Nieto-Bernaldez B, Renaud C, Dailly E, Jolliet P (2014) A fast LC-MS/MS assay for methotrexate monitoring in plasma: validation, comparison to FPIA and application in the setting of carboxypeptidase therapy . Anal Methods , 6: 178-186.
4. Allavena C, Dailly E, Reliquet V, Bonnet B, Pineau S, Andre-Garnier E, Boutoille D, Bouquié R, Raveleau A, Bouchez S, Billaud E, Raffi F (2014) Switching from Tenofovir/Emtricitabine and Nevirapine to Tenofovir/Emtricitabine/Rilpivirine Single Tablet Regimen in Virologically Suppressed, HIV-1 Infected Subjects . J Antimicrob Chemother, 69: 2804-2808.
5. Dailly E, Allavena C, Deslandes G, Bouquié R, Jolliet P, Raffi F (2014) Clinical relevance of the interaction when switching non-nucleoside reverse transcriptase inhibitors in patients infected with HIV . Curr Clin Pharmacol., 9: 399-403.
6. Bouquié R, Wainstein L, Pilet P, Mussini J, Deslandes G, Clouet J, Dailly E, Jolliet P, Victorri-Vigneau C (2014) Crushed and injected buprenorphine tablets : characteristics of princeps and generic solutions. Plos One, 9: e113991.
7. Gregoire M, Deslandes G, Renaud C, Bouquié R, Allavena C, Raffi F, Jolliet P, Dailly E (2014) A liquid chromatography-tandem mass spectrometry assay for quantification of rilpivirine and dolutegravir in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci, 971: 1-9.
8. Dailly E, Arnould J, Fraissinet F, Naux E, Letard de la Bouralière M, Bouquié R, Deslandes G, Jolliet P, Le Floch R (2013) Pharmacokinetics of ertapenem in burns patients. Int J Antimicrob Agents, 42: 48-52.
9. Dailly E, Fraissinet F, Deslandes G, Bouquié R, Jolliet P (2013) Evaluation of the QMS® Teicoplanin Immunoassay (ThermoFisher Scientific) on Cobas® 8000 System (Roche Diagnostics) and comparison to fluorescence polarization immunoassay for the determination of Teicoplanin concentrations in human plasma . J Clin Lab Anal, 27: 96-8.
10. Dailly E, Allavena C, Bouquié R, Deslandes G, Raffi F, Jolliet P (2013) Effect of efavirenz, nevirapine, etravirine, raltegravir administration on the pharmacokinetics of ritonavir-boosted darunavir in a population of HIV-infected Patients. AIDS Research and Human Retroviruses , 29(29): 42-46.
11. Bouquié R, Deslandes G, Renaud C, Dailly E, Jolliet P (2013) Validation and application of a fast semi-automated whole blood extraction for LC-MS/MS simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus - Application to high throughput routine therapeutic drug monitoring. . Anal Methods , 5: 5079-5088.
12. Dailly E, Rodallec A, Allavena C, Deslandes G, Garnier E, Billaud E, Ferré V, Reliquet V, Bouquié R, Raffi F, Jolliet P (2012) Virological response to darunavir in patients infected with HIV is linked to darunavir resistance–associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacological and combined virological/pharmacolog. Fundamental and Clinical Pharmacology, 26(4): 538-542.
13. Dailly E, Rodallec A, Allavena C, Deslandes G, Garnier E, Billaud E, Ferré V, Reliquet V, Bouquié R, Raffi F, Jolliet P (2012) Virogical response to darunavir in patients infected with HIV is linked to darunavir resistance-associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacovigical and combined virogical/pharmacological. Fundamental&clinical pharmacology, 26(4): 538-542.
14. Dailly E, Bouquié R, Deslandes G, Jolliet P, Le Floch R (2011) A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study. Analyt Technol Biomed Life, 879(15): 1137-1142.
15. Bouquié R, Deslandes G, Renaud C, Dailly E, Haloun A, Jolliet P (2011) Colchicine-induced rhabdomyolysis in a heart/lung transplant patient with concurrent use of ciclosporine, pravastatin and azithromycin. Journal of Clinical Rheumatology: .
16. Martin J, Deslandes G, Dailly E, Renaud C, Reliquet V, Raffi F, Jolliet P (2009) A liquid chromatography–tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV. J Chromatogr B Analyt Technol Biomed Life Sci: 3072-3082.
17. Dailly E, Drouineau MH, Gournay V, Rozé J, Jolliet P (2008) Population pharmacokinetics of domperidone in preterm neonates. : 1197-1200.
18. Dailly E, Raffi F, Perré P, Martin J, Deslandes G, Jolliet P (2008) Influence of darunavir co administration on nevirapine pharmacokinetics in HIV infected patients: a population approach. HIV medicine: 586-589.
19. Dailly E, Deslandes G, Hourmant M, Petit T, Renaud C, Treilhaud M, Jolliet P (2008) Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantations. Journal of Clinical Laboratory Analysis: 144-150.
20. Dailly E, Bourin M (2008) The use of benzodiazepines in the aged patient: clinical and pharmacological considerations. Pak J Pharm Sci: 144-150.
21. Dailly E, Le Floch R, Deslandes G, Pannier M, Jolliet P (2008) Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients. International Journal of Antimicrobial Agents : 537-539.
22. Dailly E, Raffi F, Biron C, Allavena C, Jolliet P (2008) Impact of nevirapine or efavirenz co administration on ritonavir-boosted amprenavir pharmacokinetics in HIV infected patients. Fundamental and Clinical Pharmacology: 101-104.

Articles dans une revue nationale

1. Gregoire M, Boutoleau-Bretonnière C, Deslandes G, Monteil-Ganière C, Bouquié R, Dailly E, Renaud C, Azoulay C, Pineau A, Grison-Hernando H, Jolliet P (2014) Early lactic acidosis following massive acetaminophen poisoning: a metabolic disorder sometimes unknown [L’acidose lactique précoce lors de l’intoxication massive au paracetamol: un trouble métabolique parfois méconnu] . Toxicologie Analytique et Clinique : sous presse.
2. Deslandes G, Bouquié R, Boels D, Gregoire M, Grison-Hernando H, Azoulay C, Pineau A, Monteil-Ganière C, Renaud C, Dailly E, Harry P, Jolliet P (2014) Accidental poisoning with brimonidine eye drops in a 9-day-old infant . Toxicologie Analytique et Clinique : sous presse.
3. Dailly E, Papuchon E, Deslandes G, Bouquié R, Jolliet P, Cantarovich D (2013) Modified mycophenolic acid pharmacokinetics after replacement of tacrolimus by sirolimus following simultaneous pancreas/kidney transplantation. Journal of Applied Biopharmaceutics and Pharmacokinetics , 1: 1-4.
4. Dailly E, Verdier M, Deslandes G, Bouquié R, Tribut O, Bentué-Ferrer D (2012) Level of evidence for Therapeutic Drug Monitoring of ceftriaxone. Thérapie, 67(2): 145-149.
5. Hulin A, Dailly E, Le Guellec C (2011) Level of evidence for Therapeutic Drug Monitoring of voriconazole. Thérapie: 109-114.
6. Dailly E, Bouquié R, Bentué-Ferrer D (2010) Therapeutic Drug Monitoring of Levetiracetam. Thérapie, 17: 28-30.
7. Bouquié R, Dailly E, Bentué-Ferrer D (2010) Therapeutic Drug Monitoring of Oxcarbazepine. Thérapie, 65: 67-70.

Participations à des projets

PARKADD : Etude du profil des malades de Parkinson développant une addiction de type comportementale au cours d'un traitement dopaminergique : aspects psychopathologiques, neurologiques et pharmacocinétiques

Communications scientifiques

Poster dans un colloque international (idpers=155)

1. Bouquié R., Deslandes G., Dailly E., Jolliet P. Heterogeneity of pholcodine dosing recommendations in paediatric population according to the French drug compendium specifications. 7èmes Congrès de Physiologie, pharmacologie et thérapeutique, 4-6 avril 2012, Dijon, 2012.
2. Dailly E., Arnould J., Fraissinet F., Naud E., Letard de la Bouralière M., Bouquié R., Deslandes G., Jolliet P., Le Floch R. Pharmacokinetics of ertapenem in burn patients. 7èmes Congrès de Physiologie, pharmacologie et thérapeutique, 4-6 avril 2012, Dijon, 2012.
3. Dailly E., Bouquié R., Deslandes G., Jolliet P., Le Floch R. A liquid chromatography assay for a simultaneous quantification of imipenem, doripenem, ertapenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study in burn patients (preliminary results). 6ème Congrès Commun de Physiologie, Pharmacologie et Thérapeutique, 22-24 mars 2011, Grenoble, 2011.
4. Bouquié R., Deslandes G., Renaud C., Dailly E., Jolliet P. A fast semi-automated whole blood extraction of immunosupressive drugs applicable to therapeutic drug monitoring : preliminary result with tacrolimus and cyclosporin A. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.
5. Deslandes G., Dailly E., Bouquié R., Lodé L., Renaud C., Jolliet P. Rapid quantification of imatinib in human plasma by high-performance liquid chromatography tandem mass spectrometry with on-line extraction. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.
6. Deslandes G., Bouquié R., Dailly E., Renaud C., Jolliet P. In-source transformation of drug metabolites: a matter to identify when using liquid chromatography electrospray tandem-mass spectrometry. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.
7. Dailly E., Deslandes G., Bouquié R., Allavena C., Raffi F., Jolliet P. Effects of protease inhibitors (lopinavir, darunavir and atazanavir) administration on trough plasma concentrations of raltegravir in experienced patients infected with VIH. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.
8. Deslandes G., Dailly E., Bouquié R., Renaud C., Jolliet P. Simultaneous determination of voriconazole, posaconazole, itraconazole and hydroxy-itraconazole concentration in human plasma by a liquid chromatography-tandem mass spectrometry assay with on-line extraction. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.

Communications orales dans un colloque national (idpers=155)

1. Dailly E. Suivi des traitement antirétroviraux chez les patients infectés par le VIH : données de pharmacocinétique de population . Recherche en Pharmaco-épidémiologie, Nantes, 2009.

Poster dans un colloque national (idpers=155)

1. Bouquié R., Deslandes G., Renaud C., Dailly E., Haloun A., Jolliet P. Rhabdomyolyse sous colchicine : A propos d'un cas chez un patient transplanté coeur/poumons traité par ciclosporine, azithromycine et pravastatine. 6èmes Congrès de Physiologie, pharmacologie et thérapeutique, 22-24 mars 2011, Grenoble, 2011.
2. Bouquié R., Deslandes G., Billaud E., Hourmant M., Dailly E., Jolliet P. Interactions attendues et inattendues entre antirétroviraux et tacrolimus, à propos d'un cas. 30ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse; 2-3 décembre 2010, Paris, 2010.
3. Monteil-Ganière C., Kergueris M., Dailly E., Victorri-Vigneau C., Pineau A., Jolliet P. Décès après consommation de méthadone. 48ème congrès de toxicologie clinique, 3-4 mai 2010, Marseille, 2010.
4. Deslandes G., Bouquié R., Talarmin J., Dailly E., Jolliet P. Perfusion continue d’amoxicilline : suivi thérapeutique ou pas ?. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.